KABRA DRUGS LTD.

KABRADG

Small Cap | Pharmaceuticals
31.31
+1.4 (+4.68%)

Stock price as on 10 Mar 2026 at 09:18 AM

Kabra drugs ltd. share price update

As of the latest trading session, Kabra Drugs Ltd. share price is currently at ₹31.31, which is up by ₹1.4 from its previous closing. Today the stock ...

Kabra Drugs Ltd. stock performance

Today’s low

₹30.1

Today’s high

₹31.31

₹31.31

52 week low

₹10.56

52 week high

₹35.52

₹31.31
Open
₹30.10
Previous close
₹29.91
Share volume
2,02,910
Total traded value (Lakh)
₹59.85
Upper circuit
₹31.40
Lower circuit
₹28.42

Kabra Drugs Ltd. fundamentals

Market cap (Cr)
₹70.50
P/E ratio (TTM)
16.88
Book value per share
₹10.96
Beta
0.52
Return on equity
0%
Earnings per share (TTM)
₹1.81
Dividend yield
0%
Net profit/quarter (Cr)
₹2.57

Kabra Drugs Ltd. financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹30.42

Operating expense

₹28.00

Net income

₹2.57

Net profit margin

8.44%

Earning per share

₹1.08

EBITDA

₹2.61

Effective tax rate

1.15%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹19.76

Operating expense

₹17.74

Net income

₹1.84

Net profit margin

9.31%

Earning per share

₹0.77

EBITDA

₹2.21

Effective tax rate

16.74%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹7.15

Operating expense

₹7.67

Net income

-₹0.50

Net profit margin

-6.99%

Earning per share

-₹0.21

EBITDA

-₹0.50

Effective tax rate

-

Particulars

Mar 25 (₹ value in crores)

Revenue

-

Operating expense

₹0.25

Net income

₹0.39

Net profit margin

-

Earning per share

₹0.21

EBITDA

₹0.40

Effective tax rate

-

Particulars

Dec 24 (₹ value in crores)

Revenue

-

Operating expense

₹0.54

Net income

-₹0.54

Net profit margin

-

Earning per share

-₹0.53

EBITDA

-₹0.54

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

-

Operating expense

₹1.73

Net income

-₹1.09

Net profit margin

-

Earning per share

-₹0.99

EBITDA

-₹1.08

Effective tax rate

-

Particulars

Mar 24 (₹ value in crores)

Revenue

-

Operating expense

₹0.74

Net income

-₹0.74

Net profit margin

-

Earning per share

-₹1.68

EBITDA

-₹0.74

Effective tax rate

-

Particulars

Mar 23 (₹ value in crores)

Revenue

-

Operating expense

₹0.34

Net income

-₹0.34

Net profit margin

-

Earning per share

-₹0.77

EBITDA

-₹0.34

Effective tax rate

-

Particulars

Mar 22 (₹ value in crores)

Revenue

-

Operating expense

₹0.19

Net income

-₹0.19

Net profit margin

-

Earning per share

-₹0.42

EBITDA

-₹0.18

Effective tax rate

-

Particulars

Mar 21 (₹ value in crores)

Revenue

-

Operating expense

₹0.18

Net income

-₹0.18

Net profit margin

-

Earning per share

-₹0.41

EBITDA

-₹0.15

Effective tax rate

-

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹10.40

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.08

EBITDA margin

-

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

-₹3.34

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

8.83

EBITDA margin

-

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

-₹1.67

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

-₹0.90

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

-₹0.47

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

-

EBITDA margin

-

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹21.29

Total assets

₹25.22

Total liabilities

₹25.22

Total equity

₹24.65

Shares outstanding

₹2.37

Price to book ratio

₹1.07

Return on assets (%)

-4.3%

Return on capital

-4.33%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹2.67

Total assets

₹4.57

Total liabilities

₹4.57

Total equity

₹1.08

Shares outstanding

₹0.43

Price to book ratio

-₹2.15

Return on assets (%)

-16.1%

Return on capital

-26.37%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

-

Total assets

₹0.70

Total liabilities

₹0.70

Total equity

-₹0.73

Shares outstanding

₹0.43

Price to book ratio

-₹3.34

Return on assets (%)

-48.02%

Return on capital

-51.92%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

-

Total assets

₹0.72

Total liabilities

₹0.72

Total equity

-₹0.39

Shares outstanding

₹0.43

Price to book ratio

-₹5.06

Return on assets (%)

-25.4%

Return on capital

-29.3%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

-

Total assets

₹1.40

Total liabilities

₹1.40

Total equity

-₹0.20

Shares outstanding

₹0.43

Price to book ratio

-

Return on assets (%)

-12.83%

Return on capital

-25.99%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

-₹1.08

Cash from operations

-₹4.70

Cash from investing

-₹0.05

Cash from financing

₹23.38

Net change in cash

₹18.62

Free cash flow

-₹4.65

Particulars

Mar 24 (₹ value in crores)

Net income

-₹0.73

Cash from operations

-₹0.20

Cash from investing

-

Cash from financing

₹2.87

Net change in cash

₹2.66

Free cash flow

-₹0.20

Particulars

Mar 23 (₹ value in crores)

Net income

-₹0.33

Cash from operations

-₹0.35

Cash from investing

-

Cash from financing

₹0.35

Net change in cash

-

Free cash flow

-₹0.35

Particulars

Mar 22 (₹ value in crores)

Net income

-₹0.18

Cash from operations

-₹0.13

Cash from investing

-

Cash from financing

₹0.12

Net change in cash

-

Free cash flow

-₹0.13

Particulars

Mar 21 (₹ value in crores)

Net income

-₹0.18

Cash from operations

-₹0.24

Cash from investing

-

Cash from financing

₹0.24

Net change in cash

-

Free cash flow

-₹0.24

Kabra Drugs Ltd. technical summary

₹29.75
-2.61 ▼
12
Bearish
4
Bullish
5 Day30.6
10 Day30.8
12 Day30.9
20 Day30.9
26 Day30.8
50 Day29.9
100 Day27.3
200 Day22.7
5 Day30.5
10 Day30.6
12 Day31
20 Day31.9
26 Day31.3
50 Day30.1
100 Day27.1
200 Day22

30.72

PIVOT

First support
₹29.83
First resistance
₹31.45
Second support
₹29.10
Second resistance
₹32.34
Third support
₹28.21
Third resistance
₹33.07
RSI
48.56
ADX
19.97
MACD
0.08
Williams % R
-72.51
Commodity Channel Index (CCI)
-56.26
Date
06 Mar 2026
Same day
41,741
Week
82,304
Month
1,25,933
1 year
0.52
3 years
0.16
Over 1 month
-0.45%
Over 1 year
189.29%
Over 3 months
11.65%
Over 3 years
76.35%
Over 6 months
58.61%
Over 6 years
48.08%

Investment Returns

Over 1 Month0.45%
Over 3 Months11.65%
Over 6 Months58.61%
Over 1 Year189.29%

Kabra Drugs Ltd. Shareholding pattern


Public
100%
Promoter holdings
0%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Kuniamuthur Nanjappan Anand

6,58,500 (2.78%)

Public Shareholding

Priyam Samir Shah

6,50,000 (2.74%)

Public Shareholding

Somisetty Malathi Latha

5,10,000 (2.15%)

Public Shareholding

Giridhar Gupta Somisetty

4,52,564 (1.91%)

Public Shareholding

Chandraprakash Jamnalal Kabra

4,00,000 (1.69%)

Public Shareholding

Promoter sharesShareCategory
Kuniamuthur Nanjappan Anand6,58,500 (2.78%)Public Shareholding
Priyam Samir Shah6,50,000 (2.74%)Public Shareholding
Somisetty Malathi Latha5,10,000 (2.15%)Public Shareholding
Giridhar Gupta Somisetty4,52,564 (1.91%)Public Shareholding
Chandraprakash Jamnalal Kabra4,00,000 (1.69%)Public Shareholding
Narendra Babu Veerla2,98,930 (1.26%)Public Shareholding
Akansha Gupta2,89,811 (1.22%)Public Shareholding
Kruti Sevanti Doshi2,74,000 (1.16%)Public Shareholding
Venkata Seshalakshmi Hanumaprasad Vemula2,70,000 (1.14%)Public Shareholding
Adusumilli Sai Raghava Pratap2,66,454 (1.12%)Public Shareholding
Priyam Sachdeva2,52,683 (1.07%)Public Shareholding
Neha Sagar Shah2,50,000 (1.05%)Public Shareholding

About KABRA DRUGS LTD.

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The Company has 500+ product

Parent Organisation

Indian Private

NSE Symbol

KABRA DRUGS LTD.

Founded

1989

KABRA DRUGS LTD. CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

PARAMPARA

PARAMPARA DAIRY DLGHT LTD

13.75
+4.5 (+48.65%)
SIROHIA

SIROHIA & SONS LIMITED

6.93
+1.15 (+19.9%)
RLF

RLF LTD.

11.85
+1.75 (+17.33%)
AMERISE

AMERISE BIOSCIENCES LIMITED

0.66
+0.06 (+10%)
View all

Top gainers

APOLLOHOSP

APOLLO HOSPITALS ENTER. L

7829
+50.00 (+0.64%)
WIPRO

WIPRO LTD

199.72
+0.97 (+0.49%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1810
+2.60 (+0.14%)
View all

Top losers

ONGC

OIL AND NATURAL GAS CORP.

266.5
-4.30 (-1.59%)
COALINDIA

COAL INDIA LTD

435.45
-2.20 (-0.50%)
BHARTIARTL

BHARTI AIRTEL LIMITED

1862.7
-4.00 (-0.21%)
POWERGRID

POWER GRID CORP. LTD.

294.85
-0.35 (-0.12%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)